MaraBio and Their Mission to Reduce the Severe Effects of Autism
)
)
In this episode of The Venari Podcast, Michael Paul discusses MaraBio's mission to mitigate the severe effects of autism.
Leveraging a ground-breaking discovery in immunology, MaraBio aims to detect, treat, and potentially prevent a subtype of autism caused by maternal autoantibodies. Paul shares his journey from research at Harvard Medical School to leading MaraBio, emphasizing the company's focus on precision medicine and the development of diagnostic tests to improve early intervention and outcomes for autism.
- The Venari Podcast
- Technology
- Leadership
)
Cristian joined Venari Partners in 2019 and specialises in executive search across digital health and healthtech. He works closely with emerging and high-growth businesses across the US and Europe, helping them build leadership teams to support their growth and commercial ambitions. His sector expertise spans SaaS, digital therapeutics, AI, virtual care, real-world evidence (RWE) and healthcare IT, with a focus on senior appointments across strategy, business development, operations and commercial functions. With extensive experience supporting healthtech companies through key stages of growth, Cristian advises on C-suite, VP and Director-level appointments, board recruitment and succession planning. He also provides specialist support with US go-to-market expansion for European businesses, alongside interim solutions, market mapping, compensation benchmarking and leadership and organisational assessments. Combining deep sector knowledge with an understanding of the challenges facing growing healthtech businesses, Cristian brings a considered approach to identifying leadership talent and supporting organisations through critical stages of development.
View Full Profile)
)
)
)
)
)
